Qing Ling

1.1k total citations
57 papers, 762 citations indexed

About

Qing Ling is a scholar working on Urology, Rheumatology and Surgery. According to data from OpenAlex, Qing Ling has authored 57 papers receiving a total of 762 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Urology, 16 papers in Rheumatology and 13 papers in Surgery. Recurrent topics in Qing Ling's work include Urinary Bladder and Prostate Research (16 papers), Pelvic floor disorders treatments (13 papers) and Acute Myeloid Leukemia Research (8 papers). Qing Ling is often cited by papers focused on Urinary Bladder and Prostate Research (16 papers), Pelvic floor disorders treatments (13 papers) and Acute Myeloid Leukemia Research (8 papers). Qing Ling collaborates with scholars based in China, United States and Taiwan. Qing Ling's co-authors include Jiaxin Wang, Yueying Yang, Jianfeng Zang, Liu Wang, Youzhou Yang, Hanchuan Tang, Xurui Liu, Yuting Zhou, Cheng Zhou and M.A. Ruda and has published in prestigious journals such as Nature Communications, Blood and Journal of Neurophysiology.

In The Last Decade

Qing Ling

54 papers receiving 753 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qing Ling China 14 231 136 131 108 102 57 762
Hak‐Sun Kim South Korea 30 632 2.7× 2.0k 14.4× 29 0.2× 16 0.1× 71 0.7× 177 3.0k
David M. Hoganson United States 15 497 2.2× 612 4.5× 37 0.3× 24 0.2× 17 0.2× 73 1.0k
Jong Keun Seon South Korea 39 875 3.8× 2.9k 21.3× 109 0.8× 149 1.4× 124 1.2× 174 4.0k
Assunta Fabozzo Italy 13 209 0.9× 301 2.2× 44 0.3× 38 0.4× 7 0.1× 39 637
R. Reihsner Austria 17 195 0.8× 289 2.1× 75 0.6× 13 0.1× 4 0.0× 44 1.0k
Marta Peña Fernández United Kingdom 16 425 1.8× 205 1.5× 55 0.4× 9 0.1× 11 0.1× 24 700
Francesco Travascio United States 20 301 1.3× 451 3.3× 11 0.1× 4 0.0× 22 0.2× 69 977
Keisuke Oe Japan 17 178 0.8× 405 3.0× 11 0.1× 15 0.1× 39 0.4× 95 1.1k
Gianfranco Beniamino Fiore Italy 26 885 3.8× 769 5.7× 96 0.7× 6 0.1× 22 0.2× 128 2.0k
Chao-Ming Chen Taiwan 15 147 0.6× 167 1.2× 104 0.8× 3 0.0× 7 0.1× 59 649

Countries citing papers authored by Qing Ling

Since Specialization
Citations

This map shows the geographic impact of Qing Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qing Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qing Ling more than expected).

Fields of papers citing papers by Qing Ling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qing Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qing Ling. The network helps show where Qing Ling may publish in the future.

Co-authorship network of co-authors of Qing Ling

This figure shows the co-authorship network connecting the top 25 collaborators of Qing Ling. A scholar is included among the top collaborators of Qing Ling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qing Ling. Qing Ling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Yucong, et al.. (2024). Transurethral surgical treatment for benign prostatic hyperplasia with detrusor underactivity: a systematic review and meta-analysis. Systematic Reviews. 13(1). 93–93. 1 indexed citations
2.
Ling, Qing, et al.. (2024). Finding Impossible Differentials in ARX Ciphers under Weak Keys. IACR Transactions on Symmetric Cryptology. 2024(1). 326–356. 2 indexed citations
3.
Pan, Jiajia, Yungui Wang, Shujuan Huang, et al.. (2024). High expression of BCAT1 sensitizes AML cells to PARP inhibitor by suppressing DNA damage response. Journal of Molecular Medicine. 102(3). 415–433. 5 indexed citations
4.
Wang, Jiaxin, et al.. (2023). Underactive Bladder and Detrusor Underactivity: New Advances and Prospectives. International Journal of Molecular Sciences. 24(21). 15517–15517. 11 indexed citations
5.
Wang, Jiaxin, Wenchao Xu, Man Liu, et al.. (2023). Transcriptomics Reveals Molecular Features of the Bilateral Pelvic Nerve Injury Rat Model of Detrusor Underactivity. Biomolecules. 13(8). 1260–1260. 1 indexed citations
6.
Ling, Qing, Jinghan Wang, Xiaofei Gao, et al.. (2023). Osteolytic lesion as initial presentation in FIP1L1-PDGFRA-rearranged myeloid/lymphoid neoplasm with eosinophilia: a case report. Annals of Hematology. 103(1). 357–360.
7.
Li, Fenglin, Qing Ling, Ying Chen, et al.. (2023). Dihydropyrimidinase‐like 2 can serve as a novel therapeutic target and prognostic biomarker in acute myeloid leukemia. Cancer Medicine. 12(7). 8319–8330. 8 indexed citations
8.
Yang, Youzhou, Jiaxin Wang, Liu Wang, et al.. (2022). Magnetic soft robotic bladder for assisted urination. Science Advances. 8(34). eabq1456–eabq1456. 56 indexed citations
10.
Wang, Daoqi, Jiahong Tan, Yinwei Chen, et al.. (2020). Combined in vitro and in silico analyses of FGFR1 variants: genotype‐phenotype study in idiopathic hypogonadotropic hypogonadism. Clinical Genetics. 98(4). 341–352. 7 indexed citations
11.
Ren, Xinyu, Yin Cheng, Shafei Wu, et al.. (2020). Primary non-Hodgkin lymphoma of the tongue base: the clinicopathology of seven cases and evaluation of HPV and EBV status. Diagnostic Pathology. 15(1). 30–30. 7 indexed citations
12.
Meng, Lingfeng, Wei Zhang, Jianye Wang, et al.. (2020). Clinical outcomes of sacral neuromodulation in non-neurogenic, non-obstructive dysuria: A 5-year retrospective, multicentre study in China. World Journal of Clinical Cases. 8(12). 2494–2501. 4 indexed citations
13.
Huang, Shujuan, Jiajia Pan, Jing Jin, et al.. (2019). Abivertinib, a novel BTK inhibitor: Anti-Leukemia effects and synergistic efficacy with homoharringtonine in acute myeloid leukemia. Cancer Letters. 461. 132–143. 18 indexed citations
14.
Meng, Lingfeng, Wei Zhang, Yaoguang Zhang, et al.. (2019). [Sacral neuromodulation preliminary outcomes in male patients with idiopathic dysuria].. PubMed. 99(34). 2675–2680. 2 indexed citations
15.
Zhang, Jing, Jian Sun, Jun Feng, et al.. (2018). Primary adrenal diffuse large B cell lymphoma: a clinicopathological and molecular study from China. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 473(1). 95–103. 8 indexed citations
17.
Yue, Xiang-an, et al.. (2018). Self-assembled microspheres feasibility study for conformance control in high temperature and high salinity reservoirs. Arabian Journal of Geosciences. 11(9). 13 indexed citations
18.
Bi, Yalan, Zhen Huo, Zhiyong Liang, et al.. (2015). Intravascular NK-cell lymphoma: a case report and review of the literature. Diagnostic Pathology. 10(1). 84–84. 15 indexed citations
19.
Sun, Jian, Jing Zhang, Qing Ling, et al.. (2014). Primary diffuse large B-cell lymphoma of the ovary is of a germinal centre B-cell-like phenotype. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 466(1). 93–100. 9 indexed citations
20.
Han, Bing, Ti Shen, Yongqiang Zhao, et al.. (2008). Primary cutaneous diffuse large B-cell lymphoma (leg type) after renal allograft: case report and review of the literature. International Journal of Hematology. 89(1). 113–117. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026